PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 22 hours 11 minutes
Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy
Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy
Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting
Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting
Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk
Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk
Metastatic Urothelial Carcinoma: Maintaining Stable Disease
Metastatic Urothelial Carcinoma: Maintaining Stable Disease
PARP Inhibitors for Recurrent Ovarian Cancer: Leveraging the Latest Tools in the Therapeutic Toolbox to Improve Patient Outcomes
PARP Inhibitors for Recurrent Ovarian Cancer: Leveraging the Latest Tools in the Therapeutic Toolbox to Improve Patient Outcomes
Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors
Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors
Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria
"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "
Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments
Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments
When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC
When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC